On Monday, the FDA approved Truvada, the first medication intended to prevent HIV infections in people having sex with infected partners. In clinical trials where HIV-negative individuals had unprotected sex with multiple partners, including some with HIV, the pill reduced the risk of infection by 42 percent compared with a placebo. Another trial with heterosexual couples where one partner was infected found that Truvada, which is taken daily, reduced the risk by 75 percent. The FDA warned that the drug, which will cost patients about $450 a year, should be used in conjunction with other prevention methods.
THE WEEK'S AUDIOPHILE PODCASTS: LISTEN SMARTER
- 7 grammar rules you really should pay attention to
- After Ferguson, we don't need another dialogue on race
- Why you should stop believing in evolution
- The secret to handling pressure like astronauts, Navy SEALs, and samurai
- In defense of Obama's golfing
- The world is on fire and neither Democrats or Republicans have a clue
- The government is getting into the fact-checking business. Be very, very afraid.
- How Democrats might goad the GOP into shutting down the government
- Wait a minute, Mr. Postman: Why postal banking won't work
- Your literary playlist: A guide to the music of Haruki Murakami
Subscribe to the Week